Event Brief
UPDATED Apr 24, 2026 at 2:04 PM ET
Apr 24, 2026 at 10:00 AM ET
FDA fast-tracks psychedelic drug research
By The BriefBrief
The FDA said it is supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders.
WHO: FDA
WHAT: fast-tracks psychedelic drug research
WHEN: Apr 24, 2026 at 9:06 AM ET
WHERE: USA
WHY: Support for psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21439 of 21439
Same format. Every time.
Continue reading — sign in or create a free account with
